共 38 条
[1]
Padberg S(2014)Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones Antimicrob Agents Chemother 58 4392-4398
[2]
Wacker E(2013)Angiotensin-II receptor 1 antagonist fetopathy – risk assessment, critical time period and vena cava thrombosis as a possible new feature Br J Clin Pharmacol 75 822-830
[3]
Meister R(2002)Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis Teratology 66 127-140
[4]
Oppermann M(2006)Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study Thromb Haemost 95 949-957
[5]
Padberg S(2014)Corticosteroid use and risk of orofacial clefts Birth Defects Res A Clin Mol Teratol 100 499-506
[6]
Kayser A(2014)Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study Arthritis Rheumatol 66 1101-1110
[7]
Van Driel D(2012)Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services Am J Med Genet A 158A 588-596
[8]
Wesseling J(2010)Birth outcomes in women who have taken leflunomide during pregnancy Arthritis Rheum 62 1494-1503
[9]
Sauer PJ(2016)Pregnancy outcomes in women who have taken leflunomide before or during pregnancy – a prospective case series Reprod Toxicol 60 186-739
[10]
Schaefer C(2015)Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study Br J Clin Pharmacol 80 727-605